A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals

Clinical Biochemistry

Volumn 46, Issue 7-8, 2013, Pages 642-651

  Kyriakopoulou, L ^a,b   Yazdanpanah, M ^a   Colantonio, D A ^a,b   Chan, M K ^a   Daly, C H ^a   Adeli, K ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CALIPER; Children; Mass spectrometry; Pediatric; Reference intervals; Serum; Steroids

Indexed keywords

ANDROSTENEDIONE; CORTICOSTERONE; CORTODOXONE; DEOXYCORTICOSTERONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PROGESTERONE; STEROID HORMONE; TESTOSTERONE; SEX HORMONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD; SENSITIVITY ANALYSIS; STEROID ANALYSIS; BLOOD; METHODOLOGY; TANDEM MASS SPECTROMETRY;

17-ALPHA-HYDROXYPROGESTERONE; ANDROSTENEDIONE; DESOXYCORTICOSTERONE; GONADAL STEROID HORMONES; HYDROCORTISONE; TANDEM MASS SPECTROMETRY; TESTOSTERONE;

EID: 84884811277     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.01.002     Document Type: Article

References (40)

1. Rauh M. Steroid measurement with LC-MS/MS in pediatric endocrinology. Mol Cell Endocrinol 2009, 301:272-281.
2. Merke D.P., Bornstein S.T. Congenital adrenal hyperplasia. Lancet 2005, 365:2125-2136.
3. Forest M.G. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update 2004, 10:469-485.
4. White P. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am 2001, 30:61-79. [vi].
5. Tonetto-Fernandes V., Lemos-Marini S.H., Kuperman H., Ribeiro-Neto L.M., Verreschi I.T., Kater C.E. Serum 21-deoxycortisol, 17-hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006, 2179-2184.
6. White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000, 21:245-291.
7. Zhang S., Mada S.R., Mattison D., Caritis S., Venkataramanan R. Development and validation of a high-performance liquid chromatography-mass spectrometric assay for the determination of 17alpha-hydroxyprogesterone caproate (17-OHPC) in human plasma. J Chromatogr 2007, 856:141-147.
8. Bose H., Sugawara T., Strauss J.R., Miller W. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 1996, 335:1870-1878.
9. Donaldson M.D., Thomas P.H., Love J.G., Murray G.D., McNinch A.W., Savage D.C. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency. Arch Dis Child 1994, 70:214-218.
10. Therrell B.L. Newborn screening for congenital adrenal hyperplasia: from genetics and biochemistry to clinical practice, part I. Clin Pediatr 2001, 40:1-16.
11. Guo T., Taylor R.L., Singh R.J., Soldin S.J. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 2006, 372:76-82.
12. Janzen N., Sander S., Terhardt M., Steuerwald U., Peter M., Das A.M., et al. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry. Steroids 2011, 76(13):1437-1442.
13. Soldin S.J., Soldin O.P. Steroid hormone analysis by tandem mass spectrometry. Clin Chem 2009, 1061-1066.
14. Magnisali P., Dracopoulou M., Mataragas M., Dacou-Voutetakis A., Moutsatsou P. Routine method for the simultaneous quantification of 17alpha-hydroxyprogesterone, testosterone, dehydroepiandrosterone, androstenedione, cortisol, and pregnenolone in human serum of neonates using gas chromatography-mass spectrometry. J Chromatogr A 2008, 1206:166-177.
15. Leinonen A., Kuuranne T., Kostiainen R. Liquid chromatography/mass spectrometry in anabolic steroid analysis-optimization and comparison of three ionization techniques: electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. J Mass Spectrom 2002, 37:693-698.
16. Raffaelli A., Saba A. Atmospheric pressure photoionization mass spectrometry. Mass Spectrom Rev 2003, 22:318-331.
17. Alary J.F. Comparative study: LC/MS/MS analysis of four steroid compounds using a new photoionization source and a conventional APCI source. Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics; 2001 May 27-31; Chicago 2001, American Society for Mass Spectrometry, Santa Fe (NM), [Abstract nr A010942].
18. Van der Kamp H.J., Oudshoorn C.G., Elvers B.H., Baarle M.V., Otten B.J., Wit J.M., et al. Cutoff levels of 17-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestation age rather than on birth weight. J Clin Endocrinol Metab 2005, 90:3904-3907.
19. Olgemöller B., Roscher A.A., Liebl B., Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab 2003, 88:5790-5794.
20. Jung B., Adeli K. Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem 2009, 42:1589-1595.
21. Schnabl K., Chan M.K., Gong Y., Adeli K. Closing the gaps in paediatric reference intervals: the CALIPER initiative. Clin Biochem Rev 2008, 29:89-96.
22. Editorial, pediatric reference intervals: critical gap analysis and establishment of a national initiative. Clin Biochem 2006, 39:559-560.
23. CALIPER Investigators Pediatric reference intervals: Critical gap analysis and establishment of a national initiative. Clin Biochem Jun 2006, 39(6):559-560.
24. 3 using tandem mass spectrometry. Clin Biochem 2009, 42(9):823-827.
25. Soldin S.J., Wong E.C. Pediatric reference intervals 2007, AACC Press, USA. 6th ed.
26. Roberts W.L., Rockwood A.L., Bunker A.M., Kushnir M.M., Meikle A.W. Limitations of the Hoffman approach to determine pediatric reference intervals for two steroids. Clin Biochem 2010, 43(10-11):933-934.
27. Colantonio D.A., Kyriakopoulou L., Chan M.K., Daly C.H., Brinc D., Venner A.A., et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012, 58(5):854-868.
28. CLSI Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. CLSI document C28-A3 2008, [Vol. Wayne (PA)]. third edition.
29. Tukey J.W. Exploratory data analysis 1977, Addison-Wesley, Boston, 688 pp.
30. Harris E.K., Boyd J.C. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990, 36:265-270.
31. Horn P.S., Pesce A.J. Reference intervals: a user's guide 2005, AACC Press, Washington (DC).
32. al Saedi S., Dean H., Dent W., Stockl E., Cronin C. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants. Pediatrics 1996, 97:100-102.
33. Tiedong G., Taylor R.L., Singh R.J., Soldin S.J. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 2006, 372:76-82.
34. Kushnir M.M., Rockwood A.L., Roberts W.L., Pattison E.G., Bunker A.M., Fitzgerald R.L., et al. Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin Chem 2006, 120-128.
35. Al-Jurayyan N.A.M. Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency in Saudi Arabia: clinical and biochemical characteristics. Acta Paediatr 1995, 84:651-654.
36. Mimouni M., Kaufman H., Roitman A., Morag C., Sadan N. Hypertension in a neonate with 11-beta-hydroxylase deficiency. Eur J Pediatr 1985, 143:231-233.
37. Rosler A., Leiberman E., Sack J., Landau H., Benderly A., Moses S.W., et al. Clinical variability of congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Hormone Res. 1982, 16:133-141.
38. Tonetto-Fernandes V., Lemos-Marini S.H.V., Kuperman H., Ribeiro-Neto L.M., Verreschi I.T.N., Kater C.E., et al. Serum 21-deoxycortisol, 17-hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11-beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006, 91:2179-2184.
39. Glenthoj A., Nielsen M.D., Starup J. Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: final diagnosis in adult age in three patients. Acta Endocrinol 1980, 93:94-99.
40. Mirmiran M., Maas Y.G., Ariagno R.L. Development of fetal and neonatal sleep and circadian rhythms. Sleep Med Rev 2003, 7(4):321-334.